German Christopher Paul
Corporate Controller & CAO
German Christopher Paul has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, German Christopher Paul is listed as Corporate Controller & CAO at RHYTHM PHARMACEUTICALS, INC. Inside the rolling window, German Christopher Paul reported no open-market purchases and 2 open-market sales totaling $931K in RYTM. The largest disclosed transaction in the window is a sale of 5,614 RYTM shares on Mar 4, 2026, worth $503K.
Companies traded
Other insiders at RYTM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$931K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has German Christopher Paul made?
German Christopher Paul has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does German Christopher Paul trade?
German Christopher Paul has filed SEC Form 4 disclosures for 1 company, including RYTM.
When was German Christopher Paul's most recent SEC Form 4 filing?
German Christopher Paul's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is German Christopher Paul's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, German Christopher Paul is listed as Corporate Controller & CAO.
What is German Christopher Paul's total buy and sell value in the current window?
Inside the rolling retention window, German Christopher Paul bought $0 and sold $931K based on SEC Form 4 filings.
What was German Christopher Paul's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,614 RYTM shares on 2026-03-04, worth $503K, per SEC Form 4 filings.